Artificial Intelligence–Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial
Clinical Gastroenterology and Hepatology · 2023-02 · 21 (2) · 337-346.e3
DOI: 10.1016/j.cgh.2022.07.006 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-02. Verfasst von Hong Xu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Endoscopy Center, First Hospital of Jilin University, Jilin, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Polyps, Adenoma. Die Arbeit wurde bisher 210-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND AND AIMS: Artificial intelligence (AI)-assisted colonoscopy improves polyp detection and characterization in colonoscopy. However, data from large-scale multicenter randomized controlled trials (RCT) in an asymptomatic population are lacking. METHODS: This multicenter RCT aimed to compare AI-assisted colonoscopy with conventional colonoscopy for adenoma detection in an asymptomatic population. Asymptomatic subjects 45-75 years of age undergoing colorectal cancer screening by direct colonoscopy or fecal immunochemical test were recruited in 6 referral centers in Hong Kong, Jilin, Inner Mongolia, Xiamen, and Beijing. In the AI-assisted colonoscopy, an AI polyp detection system (Eagle-Eye) with real-time notification on the same monitor of the endoscopy system was used. The primary outcome was overall adenoma detection rate (ADR). Secondary outcomes were mean number of adenomas per colonoscopy, ADR according to endoscopist's experience, and colonoscopy withdrawal time. This study received Institutional Review Board approval (CRE-2019.393). RESULTS: From November 2019 to August 2021, 3059 subjects were randomized to AI-assisted colonoscopy (n = 1519) and conventional colonoscopy (n = 1540). Baseline characteristics and bowel preparation quality between the 2 groups were similar. The overall ADR (39.9% vs 32.4%; P < .001), advanced ADR (6.6% vs 4.9%; P = .041), ADR of expert (42.3% vs 32.8%; P < .001) and nonexpert endoscopists (37.5% vs 32.1%; P = .023), and adenomas per colonoscopy (0.59 ± 0.97 vs 0.45 ± 0.81; P < .001) were all significantly higher in the AI-assisted colonoscopy. The median withdrawal time (8.3 minutes vs 7.8 minutes; P = .004) was slightly longer in the AI-assisted colonoscopy group. CONCLUSIONS: In this multicenter RCT in asymptomatic patients, AI-assisted colonoscopy improved overall ADR, advanced ADR, and ADR of both expert and nonexpert attending endoscopists. (ClinicalTrials.gov, Number: NCT04422548).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Endoscopy Center, First Hospital of Jilin University, Jilin, China.
- Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong SAR, China; Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong SAR, China.
- Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong SAR, China; JC School of Public Health and Primary Care, Chinese University of Hong Kong, Hong Kong SAR, China; Stanley Ho Big Data Decision Ana…
- Department of Endoscopy Center, Inner Mongolia Key Laboratory of Endoscopic Digestive Diseases, Inner Mongolia People's Hospital, Hohhot, China.
- Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong SAR, China; Department of Surgery, Chinese University of Hong Kong, Hong Kong SAR, China.
- Department of Gastroenterology, Zhongshan Hospital Affiliated to Xiamen University, Xiamen, China.
Zitieren
APA
Xu, H., Tang, R. S. Y., Lam, T. Y. T., Zhao, G., Lau, J. Y. W., Liu, Y., Wu, Q., Rong, L., Xu, W., Li, X., Wong, S. H., Cai, S., Wang, J., Liu, G., Ma, T., Liang, X., Mak, J. W. Y., Xu, H., Yuan, P., …, & Sung, J. J. Y. (2023). Artificial Intelligence–Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 21(2), 337-346.e3. https://doi.org/10.1016/j.cgh.2022.07.006
Vancouver
Xu H, Tang RSY, Lam TYT, Zhao G, Lau JYW, Liu Y, et al. Artificial Intelligence–Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial. Clinical Gastroenterology and Hepatology. 2023;21(2):337-346.e3. doi:10.1016/j.cgh.2022.07.006
BibTeX
@article{Xu2023,
author = {Xu, Hong and Tang, Raymond S Y and Lam, Thomas Y T and Zhao, Guijun and Lau, James Y W and Liu, Yunpeng and Wu, Qi and Rong, Long and Xu, Weiran and Li, Xue and Wong, Sunny H and Cai, Shuntian and Wang, Jing and Liu, Guanyi and Ma, Tantan and Liang, Xiong and Mak, Joyce W Y and Xu, Hongzhi and Yuan, Peng and Cao, Tingting and Li, Fudong and Ye, Zhenshi and Shutian, Zhang and Sung, Joseph J Y},
title = {Artificial Intelligence–Assisted Colonoscopy for Colorectal Cancer Screening: A Multicenter Randomized Controlled Trial},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {2},
pages = {337--346.e3},
doi = {10.1016/j.cgh.2022.07.006}
}
EUVIMED